## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as stated in the abstract, without access to full methods, figures, tables, or supplementary data
- **Shared manuscript claim summary** The authors used AlphaFold3 (AF3) and molecular dynamics (MD) simulations, including force-guided pulling, to study 148 missense mutations in the p53 DNA-binding domain. They report a moderate negative correlation between predicted local distance difference test (plDDT) scores and variant pathogenicity, propose two structural mechanisms of mutation-induced dysfunction (reduced DNA-binding affinity versus enhanced affinity with reduced complex stability), and identify mutations with potential rescuing effects. They compare their predictions with experimental enrichment scores (RFS) and CADD scores.
- **Visible evidence base** Abstract text only. No methods section, figures, tables, or supplementary materials were provided.
- **Missing materials affecting confidence** Full methods, all numerical results, correlation coefficients and significance values, structural figures, simulation parameters, validation of AF3 predictions against experimental structures, and details of the RFS and CADD comparisons.

## Reviewer
- **Overall assessment** The abstract presents a potentially valuable computational investigation of p53 missense mutations, addressing an important problem in cancer biology. The proposed dual mechanistic framework for mutation-induced dysfunction is conceptually interesting. However, the abstract alone provides insufficient detail to evaluate the technical rigor of the simulations, the statistical strength of the reported correlations, or the validity of the mechanistic classifications. Several claims, particularly those regarding "rescuing effects," require substantially more evidence than is presented here.
- **Who would be interested in the results, and why** Computational biophysicists and structural biologists studying protein-DNA interactions and mutation effects would find the methodological integration of AF3 with MD simulations of interest. Cancer researchers focused on p53 biology and therapeutic strategies targeting mutant p53 would be interested in the mechanistic classifications and potential rescue mutations. Researchers developing or benchmarking structure-prediction tools for variant effect prediction would also find the plDDT-pathogenicity correlation relevant.
- **Major strengths** The study addresses a clinically important problem with a large mutation set (148 variants). The integration of AF3 predictions with MD and pulling simulations represents a modern computational approach. The proposal of distinct structural mechanisms for different mutations, rather than a single uniform effect, is a thoughtful conceptual contribution. The comparison with experimental enrichment scores and CADD provides an external benchmarking element.
- **Major Concerns**
  - **Concern ID** R1-M1
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Technical soundness
  - **Claim pointer** The authors report "a moderate negative correlation between plDDT and the pathogenicity of mutant variants."
  - **Evidence pointer** Abstract, location not provided
  - **Concern** The abstract reports a correlation but provides no correlation coefficient, no confidence interval, no p-value, and no description of the statistical test used. The term "moderate" is undefined. Furthermore, plDDT is a per-residue confidence metric from AF3, and its use as a proxy for mutation-induced structural perturbation requires validation that the authors do not describe. The relationship between plDDT and pathogenicity could be confounded by sequence position, mutation type, or the underlying training data of AF3.
  - **Why it matters** This correlation appears to be a central quantitative claim of the study. Without statistical details, the reader cannot assess whether the relationship is robust or could arise from confounding factors. The claim as stated is not falsifiable from the provided information.
  - **Resolution test** Provide the correlation coefficient, sample size, p-value or confidence interval, and a description of the statistical method. Demonstrate that the correlation is not an artifact of AF3's confidence calibration by comparing with experimental structures or an independent prediction method. Show a scatter plot or equivalent visualization.
  - **Concern ID** R1-M2
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Technical soundness
  - **Claim pointer** The authors state that "some mutations, such as R248P and N239S, reduce the binding affinity of the p53-DNA complex, whereas others, such as C238Y and P278R, enhance affinity but compromise the structural stability of the complex."
  - **Evidence pointer** Abstract, location not provided
  - **Concern** The abstract provides no quantitative metrics for binding affinity or structural stability. It is unclear whether "binding affinity" refers to computed binding free energies, forces from pulling simulations, or some other proxy. The threshold for classifying a mutation as "affinity-reducing" versus "stability-compromising" is not defined. The selection of only four example mutations out of 148 raises questions about how representative these are and whether the classification scheme is consistent across the full set.
  - **Why it matters** The two-mechanism model is a central conceptual contribution of the study. If the classification criteria are arbitrary or inconsistent, the model loses its explanatory power. The reader cannot evaluate whether the proposed mechanisms are robust or are artifacts of the simulation setup.
  - **Resolution test** Define the quantitative metrics used for affinity and stability, specify the classification thresholds, and report the number of mutations falling into each category. Provide validation that the computed affinities correlate with experimental binding data where available. Show that the classification is stable across simulation replicates or alternative analysis methods.
  - **Concern ID** R1-M3
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Claim support
  - **Claim pointer** The authors state that "we uncovered mutations with potential rescuing effects, such as E285A and M243T, which preserved structural stability and enhanced the DNA-binding ability."
  - **Evidence pointer** Abstract, location not provided
  - **Concern** The term "rescuing effects" is a strong claim that implies these mutations could restore function to otherwise dysfunctional p53. The abstract provides no evidence that these mutations occur in a pathogenic context, no comparison with wild-type p53 function, and no experimental validation. The claim that a mutation "enhances" DNA-binding ability relative to what baseline is unclear. If the baseline is wild-type p53, then the claim is that these mutations make p53 bind DNA more strongly than the native protein, which would require careful thermodynamic validation.
  - **Why it matters** The suggestion of rescue mutations has potential therapeutic implications. Overstating this finding based on computational predictions alone could mislead researchers pursuing experimental follow-up. The claim as stated goes beyond what computational predictions can establish without experimental corroboration.
  - **Resolution test** Clarify the baseline for comparison. If the claim is relative to wild-type, provide binding free energy differences with error estimates and demonstrate that the effect is robust across simulation conditions. If the claim is relative to other mutants, state this explicitly. Temper the language to "predicted to preserve stability and enhance binding" unless experimental validation is provided.
  - **Concern ID** R1-M4
  - **Severity** Major
  - **Blocking** No
  - **Axis** Technical soundness
  - **Claim pointer** The authors state that they "compared the results of our study with experimental in vitro enrichment scores (RFS) and Combined Annotation Dependent Depletion (CADD)."
  - **Evidence pointer** Abstract, location not provided
  - **Concern** The abstract does not report the outcome of this comparison. No correlation coefficients, concordance statistics, or qualitative agreement levels are given. It is unclear whether the comparison validated the computational predictions or revealed discrepancies.
  - **Why it matters** The comparison with experimental data is a key element for establishing the credibility of the computational approach. Without reporting the results, the reader cannot judge whether the simulations have predictive value or whether the proposed mechanisms align with experimental observations.
  - **Resolution test** Report the quantitative results of the comparison with RFS and CADD, including correlation coefficients, significance levels, and a discussion of any discordant cases.
- **Minor Comments**
  - **Concern ID** R1-m1
  - **Severity** Minor
  - **Axis** Readability
  - **Affected element** Abstract, first sentence
  - **Evidence pointer** Abstract, location not provided
  - **Issue** The phrase "crucial regulator of genomic integrity" is generic and could apply to many tumor suppressors. The abstract would benefit from a more specific statement of p53's function, such as its role in transcriptional regulation of cell cycle and apoptosis genes.
  - **Required correction** Revise to specify p53's transcriptional function or its role in DNA damage response pathways.
  - **Concern ID** R1-m2
  - **Severity** Minor
  - **Axis** Technical soundness
  - **Affected element** Abstract, methods description
  - **Evidence pointer** Abstract, location not provided
  - **Issue** The abstract mentions "force-guided pulling simulations" without explaining what this entails. This technique is not standard in the field, and the reader cannot assess its appropriateness without more detail.
  - **Required correction** Add a brief description of the pulling simulation protocol or cite a reference for the method.
  - **Concern ID** R1-m3
  - **Severity** Minor
  - **Axis** Readability
  - **Affected element** Abstract, final sentence
  - **Evidence pointer** Abstract, location not provided
  - **Issue** The statement that the study "highlights the value of integrative computational approaches" is a generic conclusion that does not add specific information. The abstract would be stronger if it stated what specific insight the integration of AF3 and MD provided that either method alone could not.
  - **Required correction** Replace the generic statement with a specific take-home message about the mechanistic insights gained.
  - **Concern ID** R1-m4
  - **Severity** Minor
  - **Axis** Technical soundness
  - **Affected element** Abstract, mutation selection
  - **Evidence pointer** Abstract, location not provided
  - **Issue** The abstract states that 148 missense variants were "located within its DNA-binding interface" but does not specify how this interface was defined. Different definitions could lead to different mutation sets.
  - **Required correction** Briefly state the criterion used to define the DNA-binding interface, such as a residue distance cutoff from DNA in the crystal structure.
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The correlation claim lacks statistical support, the mechanistic classification lacks defined criteria and quantitative metrics, and the "rescuing effects" claim is overstated relative to the evidence presented.
- **Assessment against Nature-style criteria**  
  *Originality*: The application of AF3 to a large panel of p53 mutations with subsequent MD validation is moderately original, though the general approach of combining structure prediction with MD is not new. The two-mechanism model is a potentially original conceptual contribution.  
  *Scientific importance*: The problem is important given p53's central role in cancer. However, the abstract does not demonstrate that the findings advance understanding beyond what is already known about p53 mutation effects.  
  *Interdisciplinary readership*: The work sits at the interface of computational biology, structural biology, and cancer research. The abstract is written in a way that is accessible to these communities, though specialists in each area would need more detail.  
  *Technical soundness*: Cannot be adequately assessed from the abstract alone. The missing statistical details and undefined metrics are significant concerns.  
  *Readability for nonspecialists*: The abstract is generally clear, but terms such as "plDDT," "RFS," and "force-guided pulling" are not explained for readers outside the computational biology field.

## Risk / unsupported claims
- The claim of a "moderate negative correlation between plDDT and pathogenicity" is unsupported without statistical details.
- The classification of mutations into "affinity-reducing" versus "stability-compromising" categories is unsupported without defined metrics and thresholds.
- The claim of "rescuing effects" for E285A and M243T is unsupported and potentially overstated given the absence of experimental validation or a clear baseline for comparison.
- The statement that the findings "provide a comprehensive framework for understanding the molecular mechanisms underlying p53 mutations" is not supported by the abstract alone, as the framework is only partially described.
- The comparison with RFS and CADD is mentioned but no results are reported, making the outcome of this comparison unassessable.